EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL: Who Reports Side Effects? Age, Gender & Country Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Gender Distribution
25.7%
Female
74.3%
Male
Age Information
The average age of patients reporting adverse events with EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL is 48.7 years.
Geographic Distribution
The majority of adverse event reports for EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL originate from US.
Report Summary & Outcomes
18,558
Total Reports
18,558
As Primary/Secondary Suspect
429
Deaths Reported
1,627
Hospitalizations
101
Life-Threatening
89
Disabilities
Reporting Timeline
First adverse event report: 10100610. Most recent report: 20250823. View full timeline →